share_log

Scinai Immunotherapeutics Share Are Trading Higher After the Company Announced Today the Establishment of a U.S.-based Subsidiary for Its Contract Development and Manufacturing Services.

Benzinga ·  Dec 16 22:26
Scinai Immunotherapeutics Share Are Trading Higher After the Company Announced Today the Establishment of a U.S.-based Subsidiary for Its Contract Development and Manufacturing Services.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment